易瑞生物：控股股东及一致行动人合计减持2.6366%

Core Viewpoint - The major shareholders of Yirui Biotechnology, including Yirui Venture Capital and its affiliates, have completed a share reduction, selling a total of 10.68 million shares, which represents 2.6366% of the total share capital [1] Share Reduction Details - Yirui Venture Capital reduced its holdings by 3.82 million shares through centralized bidding at an average price of 9.85 yuan per share and 6.23 million shares through block trading at an average price of 8.81 yuan per share [1] - Yidazhi reduced its holdings by 38,400 shares through centralized bidding at an average price of 9.85 yuan per share and 250,000 shares through block trading at an average price of 9.76 yuan per share [1] - Yikaire reduced its holdings by 91,800 shares through centralized bidding at an average price of 9.85 yuan per share and 25,000 shares through block trading at an average price of 9.76 yuan per share [1] Post-Reduction Shareholding Structure - After the reduction, Yirui Venture Capital holds 122 million shares, accounting for 30.1973% of the total shares [1] - Yidazhi holds 18.7196 million shares, accounting for 4.6213% of the total shares [1] - Yikaire holds 22.2354 million shares, accounting for 5.4893% of the total shares [1] - The combined holdings of the three parties amount to 223 million shares, representing 55.1625% of the total shares [1]